Stock Region Penny Picks
Stock Region Penny Picks Watchlist: October 7, 2025
Stock Region Penny Picks Watchlist: October 7, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The following is for informational and entertainment purposes only. It is not financial advice. The stock market is volatile, so please do your own research and due diligence before making any investment decisions. We may or may not hold positions in the stocks mentioned.
Hey Stock Region fam,
Hope you had a killer trading day. It’s been a wild ride, and the market is throwing some interesting opportunities our way. Before we dive into the juicy stuff, here’s our standard but crucial heads-up.
Alright, let’s get into the stocks that are making moves and catching our eye.
$LXEO - Lexeo Therapeutics
Lexeo is making some serious waves. They just announced progress with the FDA for an accelerated approval pathway for their LX2006 drug. On top of that, they dropped positive interim clinical data. Any time you see “FDA” and “positive data” in the same sentence, it’s a massive green flag. Biotech can be a rollercoaster, but this is the kind of news that can really ignite a stock. Keep a close eye on this one; the momentum could build quickly.
$ZNB - Zeta Network Group
Crypto meets traditional finance here. Zeta is partnering with SOLV Foundation to push Bitcoin-centric finance. This is a smart strategic move, bridging two powerful worlds. While the crypto market has its own unique volatility, partnerships like this can lend legitimacy and drive adoption. It’s an interesting long-term play for those who believe in the convergence of TradFi and DeFi.
$MBOT - Microbot Medical
Money talks, and Microbot just heard a lot of it. They announced the final closing of a deal bringing in up to $92.2 million in gross proceeds. That’s a huge cash injection. This kind of funding can fuel research, development, and expansion, giving them a much longer runway. It’s a vote of confidence from investors, and that’s something we love to see.
$COCH - Envoy Medical
Another big FDA win on our list! Envoy received FDA approval to advance its clinical trial to the final stage. This is based on promising three-month data. Getting to the final stage is a major milestone that de-risks the venture significantly. It’s not a guarantee, but it’s a huge step closer to commercialization. This could be a slow-burner that pays off big time.
$PAPL - Pineapple
Pineapple is going big on digital assets, launching a $100 million treasury strategy focused on Injective ($INJ). They’ve already made their first purchase. This shows serious conviction in the Injective ecosystem. When a company puts that much capital behind a specific digital asset, it can create a ripple effect, driving both interest and value. A bold, high-conviction move worth watching.
$WETH - WeTouch Technology Inc.
Talk about a blockbuster quarter. WeTouch reported its fiscal Q1 2025 results, and they are stunning. Net income surged over fourfold, and their cash position is now at $8.90 per share. The market seemed to notice, with the stock trading at a fraction of that. A company with that much cash and soaring profits trading at such a low valuation? That screams opportunity to me. This one feels undervalued.
$TGL - Treasure Global
Insiders are putting their money where their mouth is. Treasure Global announced a $400,000 strategic investment from their own Executive Director and another investor. Insider buying is one of the most powerful signals in the market. It tells you that the people who know the company best are bullish on its future. This investment is aimed at advancing expansion plans, which is exactly what you want to see.
$VRCA - Verrica Pharmaceuticals
Verrica is heading to a major medical conference (SITC Annual Meeting) to present new data from its Phase 2 trial. Presentations at prestigious events like this can put a company in the spotlight, attracting attention from both the medical community and investors. Positive data presented on a big stage can often act as a powerful catalyst for a stock. This is one to watch leading up to the event.
That’s a wrap for today’s watchlist. Some incredible developments across biotech, tech, and crypto. As always, things can change in a flash, so stay sharp and manage your risk.
Happy trading,
The Stock Region Team
Final Disclaimer: Investing carries risk, and you could lose some or all of your investment. The information provided in this newsletter is not a recommendation to buy or sell any security. Always consult with a licensed financial advisor before making investment decisions.